ADC Therapeutics SA (ADCT)
4.19
+0.01
(+0.24%)
USD |
NYSE |
Dec 12, 12:40
ADC Therapeutics EPS Diluted (Quarterly): -0.3002 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alcon AG | 0.4779 |
| BeOne Medicines Ltd. | 1.092 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
| Addex Therapeutics Ltd. | -2.099 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -40.97M |
| Revenue (Quarterly) | 16.43M |
| Total Expenses (Quarterly) | 57.39M |
| Enterprise Value | 740.50M |
| Gross Profit Margin (Quarterly) | 91.95% |
| Profit Margin (Quarterly) | -249.4% |
| Earnings Yield | -34.60% |
| Normalized Earnings Yield | -34.29 |